HCW Biologics prices $5.0M follow-on offering at $7.45/unit, amends existing warrants

HCW Biologics Inc.

671,140 units priced at $7.45/unit, each consisting of one share (or pre-funded warrant) and two warrants.
Gross proceeds of $5.0M; closed May 15, 2025; Maxim Group as sole placement agent.
Amended existing warrants for 167,925 shares, reducing exercise price from $41.20 to $7.45 per share.
Warrants exercisable immediately at $7.45, expire in five years; pre-funded warrants at $0.0001, no expiration.
Proceeds to fund clinical trials for HCW9302, business development, R&D, and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.